May 5, 2020 / 9:38 PM / a month ago

BRIEF-Iovance Biotherapeutics Q1 Loss Per Share $0.55

May 5 (Reuters) - Iovance Biotherapeutics Inc:

* IOVANCE BIOTHERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

* Q1 LOSS PER SHARE $0.55

* Q1 EARNINGS PER SHARE ESTIMATE $-0.51 — REFINITIV IBES DATA

* IOVANCE - AT MARCH 31, 2020, HELD $251.2 MILLION IN CASH, CASH EQUIVALENTS, SHORT-TERM INVESTMENTS AND RESTRICTED CASH VERSUS $312.5 MILLION AT DECEMBER 31, 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below